Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 515.13 BATS BZX Real-Time Price As of 9:40am ET |  -2.05 / -0.40%Today’s Change | 441.00 Today|||52-Week Range 664.64 | +6.63% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 517.18 |
| Today’s open | 507.45 |
| Day’s range | 514.12 - 519.74 |
| Volume | 4,662 |
| Average volume (3 months) | 978,822 |
| Market cap | $52.9B |
Data as of 9:40am ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | +68.51% |
| Earnings growth (this year) | +51.39% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | +8.06% |
| P/E ratio | 14.6 |
| Price/Sales | 6.54 |
| Price/Book | 4.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TAKTakeda Pharmaceutica... | +0.11 | +0.68% |
| VRTXVertex Pharmaceutica... | -0.64 | -0.30% |
| ---- | ||
| ---- |
Data as of 9:40am ET, 05/14/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $17.94 |
| Annual revenue (last year) | $8.5B |
| Annual profit (last year) | $3.5B |
| Net profit margin | 41.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
